Stocks 1,689 records
| Ticker | Company | Sector | Price | Revenue Estimate | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
 | Eli Lilly and Company | Healthcare | $1,179.27 ≈ 1,052.50 € | 938.15B | 39.26 | 24.76 | 0.59% | -1.61% | +8.32% | +38.3% | FY Cur +35.78% (28) Q Cur +27.08% (14) FY Next +15.65% (28) Q Next +4.56% (15) | |
 | Johnson & Johnson | Healthcare | $261.44 ≈ 233.34 € | 562.31B | 29.71 | 21.26 | 2.09% | -0.76% | +23.96% | +35.21% | FY Cur +7.66% (12) Q Cur +5.84% (10) FY Next +7.04% (11) Q Next +4.27% (9) | |
 | AbbVie Inc. | Healthcare | $276.47 ≈ 246.75 € | 436.04B | 78.1 | 17.01 | 2.54% | +0.39% | +18.58% | +17.81% | FY Cur +10.53% (24) Q Cur +9.79% (18) FY Next +8.80% (23) Q Next +5.55% (17) | |
 | Merck & Company, Inc. | Healthcare | $145.60 ≈ 129.95 € | 320.6B | 115.56 | 15.62 | 2.39% | -0.29% | +34.24% | +64.79% | FY Cur +3.18% (24) Q Cur +0.29% (16) FY Next +4.39% (24) Q Next -3.04% (15) | |
 | ROCHE I | Healthcare | 366.60 CHF ≈ 394.02 € | 313.94B | 23.91 | 16.66 | 2.71% | -2.11% | +7.7% | +18.05% | FY Cur +2.26% (13) Q Cur +5.49% (3) FY Next +4.60% (15) Q Next +4.42% (2) | |
 | ROCHE PS | Healthcare | 357.80 CHF ≈ 384.56 € | 306.41B | 23.34 | 16.33 | 2.78% | +1.45% | +9.02% | +21.87% | FY Cur +2.26% (13) Q Cur +5.49% (3) FY Next +4.60% (15) Q Next +4.42% (2) | |
 | UnitedHealth Group Incorporated | Healthcare | $379.30 ≈ 338.53 € | 303.86B | 23.86 | 16.78 | 2.50% | -1.34% | +11.68% | +0.28% | FY Cur -0.11% (19) Q Cur -1.48% (18) FY Next +2.96% (21) Q Next -0.23% (17) | |
 | Novartis AG | Healthcare | $143.75 ≈ 128.30 € | 243.86B | 21.71 | 14.67 | 3.31% | -0.12% | +3.16% | +8.16% | FY Cur +1.72% (21) Q Cur +2.03% (8) FY Next +6.39% (21) Q Next +2.34% (7) | |
 | NOVARTIS N | Healthcare | 119.10 CHF ≈ 128.01 € | 243.31B | 22.69 | 12.1 | 3.14% | +1.17% | +8.67% | +11.71% | FY Cur +1.72% (21) Q Cur +2.03% (8) FY Next +6.39% (21) Q Next +2.34% (7) | |
 | ASTRAZENECA PLC ORD SHS $0.25 | Healthcare | 11,998.00 p ≈ 141.73 € | 219.81B | 24.04 | 1.05K | 2.01% | -2.36% | -13.51% | -7.14% | FY Cur +7.52% (27) Q Cur +5.54% (11) FY Next +6.16% (27) Q Next +4.09% (10) | |
 | Thermo Fisher Scientific Inc | Healthcare | $658.02 ≈ 587.28 € | 217.15B | 35.42 | 23.86 | 0.29% | -1.52% | +11.75% | +21.59% | FY Cur +7.45% (25) Q Cur +7.45% (19) FY Next +5.15% (25) Q Next +8.03% (17) | |
 | Amgen Inc. | Healthcare | $414.87 ≈ 370.27 € | 200.18B | 25.77 | 16.94 | 2.47% | -1.37% | +23.96% | +38.29% | FY Cur +5.98% (31) Q Cur +5.15% (24) FY Next +3.62% (31) Q Next +2.19% (23) | |
 | Gilead Sciences, Inc. | Healthcare | $151.17 ≈ 134.92 € | 167.29B | - | 15.24 | 2.23% | +0.17% | +19.42% | +24.4% | FY Cur +4.36% (25) Q Cur +0.17% (20) FY Next +6.57% (24) Q Next +4.63% (17) | |
 | Abbott Laboratories | Healthcare | $99.60 ≈ 88.89 € | 154.83B | 31.82 | 16.42 | 2.56% | -0.24% | -21.7% | -26.65% | FY Cur +13.25% (27) Q Cur +14.30% (24) FY Next +8.62% (27) Q Next +4.21% (23) | |
 | Novo Nordisk A/S | Healthcare | $38.64 ≈ 34.49 € | 152.23B | 9.45 | 1.75 | 4.71% | -0.21% | -25.46% | -35.95% | FY Cur -2.68% (27) Q Cur -2.15% (11) FY Next +1.35% (27) Q Next +3.34% (9) | |
 | Novo Nordisk B A/S | Healthcare | 255.25 kr ≈ 34.12 € | 150.61B | 9.74 | 11.64 | 4.68% | -1.58% | -23.17% | -34.99% | FY Cur -2.68% (27) Q Cur -2.15% (11) FY Next +1.35% (27) Q Next +3.34% (9) | |
 | Novo Nordisk B A/S | Healthcare | 255.25 kr ≈ 34.12 € | 150.61B | 9.74 | 11.64 | 4.68% | -1.58% | -23.17% | -34.99% | FY Cur -2.68% (27) Q Cur -2.15% (11) FY Next +1.35% (27) Q Next +3.34% (9) | |
 | Pfizer, Inc. | Healthcare | $28.28 ≈ 25.24 € | 143.86B | 37.21 | 9.76 | 6.18% | -0.64% | +11.32% | +8.33% | FY Cur -0.56% (25) Q Cur -4.56% (16) FY Next -3.69% (25) Q Next +6.07% (15) | |
 | Danaher Corporation | Healthcare | $219.81 ≈ 196.18 € | 137.91B | 38.77 | 23.64 | 0.74% | -0.47% | -5.73% | +6.1% | FY Cur +7.26% (23) Q Cur +8.37% (19) FY Next +8.09% (23) Q Next +15.68% (17) | |
 | Intuitive Surgical, Inc. | Healthcare | $423.96 ≈ 378.38 € | 133.67B | 48.62 | 35 | 0.00% | +0.21% | -27.46% | -7.29% | FY Cur +16.80% (31) Q Cur +16.04% (25) FY Next +12.83% (31) Q Next +10.50% (24) | |
 | Vertex Pharmaceuticals Incorpor | Healthcare | $510.08 ≈ 455.25 € | 115.31B | 29.71 | 25.23 | 0.00% | -0.47% | +10.91% | +19.49% | FY Cur +10.45% (16) Q Cur +11.16% (13) FY Next +9.84% (16) Q Next +3.20% (14) | |
 | Bristol-Myers Squibb Company | Healthcare | $59.12 ≈ 52.76 € | 107.78B | 13.02 | 8.96 | 4.23% | -0.2% | +9.91% | +33.77% | FY Cur +3.49% (25) Q Cur +3.95% (20) FY Next -3.02% (25) Q Next -0.11% (19) | |
 | Medtronic plc. | Healthcare | $88.48 ≈ 78.97 € | 101.01B | 21.74 | 13.79 | 3.28% | +2.62% | -9.22% | -10.34% | FY Cur +7.30% (27) Q Cur +5.82% (23) FY Next +3.65% (27) Q Next +0.45% (22) | |
 | CVS Health Corporation | Healthcare | $86.16 ≈ 76.90 € | 98.35B | 22.67 | 10.1 | 3.03% | -0.17% | +9.96% | +14.13% | FY Cur +3.97% (21) Q Cur +1.88% (18) FY Next +2.87% (22) Q Next +2.06% (18) | |
 | McKesson Corporation | Healthcare | $938.84 ≈ 837.91 € | 97.69B | 25.16 | 18.56 | 0.40% | +2.19% | +12.44% | +23.09% | FY Cur +7.05% (12) Q Cur +6.61% (11) FY Next +6.89% (12) Q Next +2.97% (11) | |
 | Stryker Corporation | Healthcare | $277.33 ≈ 247.52 € | 94.94B | 28.74 | 16.61 | 1.27% | +0.57% | -21.79% | -26.2% | FY Cur +8.34% (27) Q Cur +9.46% (25) FY Next +8.61% (27) Q Next +20.24% (24) | |
 | HCA Healthcare, Inc. | Healthcare | $451.09 ≈ 402.60 € | 89.31B | 15.12 | 14.09 | 0.70% | +1.33% | -5.97% | +4.4% | FY Cur +3.87% (23) Q Cur +0.90% (21) FY Next +3.91% (23) Q Next +2.66% (21) | |
 | Sanofi | Healthcare | $40.07 ≈ 35.76 € | 85.69B | 21.09 | 7.59 | 6.01% | +0.07% | -17.46% | -17.56% | FY Cur +8.51% (14) Q Cur +6.31% (6) FY Next +6.54% (13) Q Next -5.00% (6) | |
 | SANOFI | Healthcare | 71.52 € | 85.69B | 22.01 | 7.9 | 5.81% | -1.23% | -14.54% | -16.15% | FY Cur +8.51% (14) Q Cur +6.31% (6) FY Next +6.54% (13) Q Next -5.00% (6) | |
 | GSK PLC ORD 31 1/4P | Healthcare | 1,750.00 p ≈ 20.67 € | 82.84B | 14.83 | 919.87 | 3.92% | -3.07% | -5.19% | +7.1% | FY Cur +3.83% (22) Q Cur +3.56% (8) FY Next +4.68% (20) Q Next +1.29% (8) | |
 | GSK PLC | Healthcare | Mex$ 849.00 ≈ 40.84 € | 81.82B | 14.86 | - | 3.79% | 0% | -1.74% | +4.43% | FY Cur +3.83% (22) Q Cur +3.56% (8) FY Next +4.68% (20) Q Next +1.29% (8) | |
 | Moderna, Inc. | Healthcare | $225.00 ≈ 200.81 € | 80.17B | - | -50.7 | 0.00% | +0.26% | +547.81% | +605.59% | FY Cur +8.09% (21) Q Cur -12.17% (14) FY Next +16.07% (19) Q Next -24.31% (13) | |
 | Elevance Health, Inc. | Healthcare | $412.70 ≈ 368.33 € | 79.88B | 18.27 | 13.95 | 1.72% | -0.83% | +14.95% | +10.65% | FY Cur -0.58% (12) Q Cur -1.84% (11) FY Next +1.93% (11) Q Next -2.02% (10) | |
 | WUXI APPTEC | Healthcare | HK$ 208.00 ≈ 23.65 € | 71.78B | 25.24 | 23.38 | 0.56% | -0.48% | +108.1% | +74.2% | FY Cur +32.53% (19) Q Cur +27.51% (2) FY Next +19.63% (20) Q Next +3.55% (2) | |
 | Regeneron Pharmaceuticals, Inc. | Healthcare | $746.54 ≈ 666.29 € | 68.6B | 18.46 | 12.11 | 0.51% | -0.34% | -4.44% | +31.16% | FY Cur +20.31% (25) Q Cur +20.96% (19) FY Next +7.56% (23) Q Next +8.04% (18) | |
 | ESSILORLUXOTTICA | Healthcare | 146.35 € | 67.13B | 27.36 | 18.58 | 2.80% | -2.49% | -47.19% | -48.69% | FY Cur +5.68% (20) Q Cur +7.13% (7) FY Next +8.12% (20) Q Next +7.54% (1) | |
 | The Cigna Group | Healthcare | $282.43 ≈ 252.07 € | 66.61B | 11.68 | 8.43 | 2.22% | +0.9% | +1.65% | -8.39% | FY Cur +4.57% (16) Q Cur +3.88% (13) FY Next +4.07% (16) Q Next +2.94% (13) | |
 | WUXI APPTEC CO LTD | Healthcare | ¥157.80 ≈ 21.03 € | 63.81B | 21.38 | 16.73 | 1.29% | -2.59% | +71.71% | +39.83% | FY Cur +32.53% (19) Q Cur +27.51% (2) FY Next +19.63% (20) Q Next +3.55% (2) | |
 | MERCK KGAA I | Healthcare | 137.85 € | 59.93B | 26.11 | 15.46 | 1.57% | -3.18% | +10.69% | +13.04% | FY Cur +1.78% (14) Q Cur +0.89% (3) FY Next +5.43% (14) Q Next +0.60% (3) | |
 | CHUGAI PHARMACEUTICAL CO | Healthcare | ¥6,019 ≈ 33.94 € | 55.86B | 20.99 | - | 2.16% | -1.44% | -26.98% | -18.14% | FY Cur +10.92% (14) Q Cur +4.53% (6) FY Next +10.15% (14) Q Next +5.46% (6) | |
 | Boston Scientific Corporation | Healthcare | $42.73 ≈ 38.14 € | 55.27B | 17.3 | 12.63 | 0.00% | +1.11% | -56.21% | -56.57% | FY Cur +5.56% (26) Q Cur +1.09% (23) FY Next +4.77% (27) Q Next +5.57% (21) | |
 | Cencora, Inc. | Healthcare | $323.85 ≈ 289.04 € | 55.16B | 24.04 | 16.35 | 0.75% | +1.29% | -5.5% | +3.46% | FY Cur +4.89% (12) Q Cur +4.97% (9) FY Next +4.59% (7) Q Next +1.98% (5) | |
 | CSL FPO [CSL] | Healthcare | A$ 183.84 ≈ 114.62 € | 55.01B | - | 27.74 | 2.23% | +1.31% | +6.48% | -11.19% | FY Cur -0.26% (17) Q Cur - (0) FY Next +3.55% (17) Q Next - (0) | |
 | Takeda Pharmaceutical Company L | Healthcare | $18.73 ≈ 16.72 € | 53.4B | - | - | 3.33% | +0.82% | +18.49% | +29.42% | FY Cur +1.78% (16) Q Cur +3.56% (6) FY Next +1.85% (16) Q Next +6.21% (6) | |
 | TAKEDA PHARMACEUTICAL CO LTD | Healthcare | ¥5,843 ≈ 32.95 € | 52.63B | - | - | 3.51% | +0.46% | +20.85% | +34.76% | FY Cur +1.78% (16) Q Cur +3.56% (6) FY Next +1.85% (16) Q Next +6.21% (6) | |
 | Natera, Inc. | Healthcare | $400.71 ≈ 357.63 € | 51.55B | - | -2.03K | 0.00% | -1.21% | +69.92% | +127.08% | FY Cur +26.17% (22) Q Cur +19.45% (20) FY Next +20.65% (22) Q Next +5.85% (18) | |
 | BEIGENE LTD | Healthcare | ¥249.42 ≈ 33.24 € | 49.15B | 83.14 | 45.69 | 0.00% | -0.45% | -8.3% | -18.08% | FY Cur +26.72% (31) Q Cur +24.34% (12) FY Next +14.92% (32) Q Next +1.74% (12) | |
 | Cardinal Health, Inc. | Healthcare | $237.57 ≈ 212.03 € | 49.1B | 32.86 | 16.9 | 0.86% | +2.93% | +15.32% | +51.46% | FY Cur +4.53% (15) Q Cur +3.91% (11) FY Next +6.05% (15) Q Next +2.67% (11) | |
 | HOYA CORP | Healthcare | ¥25,055 ≈ 141.30 € | 47.13B | 31.71 | - | 1.18% | +0.12% | +5.78% | +12.66% | FY Cur +6.36% (15) Q Cur +11.44% (8) FY Next +8.25% (15) Q Next +2.21% (9) | |
 | argenx SE | Healthcare | $825.03 ≈ 736.34 € | 46.31B | 31.19 | 23.76 | 0.00% | -11.83% | -2.3% | +2.46% | FY Cur +48.20% (4) Q Cur +43.13% (2) FY Next +21.64% (4) Q Next +8.94% (2) |
Rows per page:
Page 1 of 34
Results: 1,689
USMkt Cap
115.31B
P/E 29.71
+19.49% 1Y
Results 1 - 50 of 1,689
Per page:
Page 1 / 34